Lumacaftor-ivacaftor in the treatment of cystic fibrosis: design, development and place in therapy
GJ ConnettNational Institute for Health Research, Southampton Respiratory Biomedical Research Centre, University Hospital Southampton NHS Foundation Trust, Southampton, SO16 6YD, UKAbstract: Lumacaftor-ivacaftor is a combination of two small molecule therapies targeting the basic defect in cystic fi...
| Main Author: | |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Dove Medical Press
2019-07-01
|
| Series: | Drug Design, Development and Therapy |
| Subjects: | |
| Online Access: | https://www.dovepress.com/lumacaftor-ivacaftor-in-the-treatment-of-cystic-fibrosis-design-develo-peer-reviewed-article-DDDT |